Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel Bethmann
Pd57-06 Altered Immune Cell Repertoire and Activity After Checkpoint Blockade Immunotherapy With Nivolumab in Renal Cell Carcinoma
Journal of Urology
Urology
Association of Caspase 8 Polymorphisms -652 6N InsDel and Asp302His With Progression-Free Survival and Tumor Infiltrating Lymphocytes in Early Breast Cancer
Scientific Reports
Multidisciplinary
Related publications
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Macrophage Checkpoint Blockade and Tumor Mechanics in a Cell-Based Immunotherapy
Biophysical Journal
Biophysics
Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab
Clinical Genitourinary Cancer
Oncology
Urology
Altered Glutamate Cysteine Ligase Expression and Activity in Renal Cell Carcinoma
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
Frontiers in Oncology
Cancer Research
Oncology
Complete Remission of Bone Metastases in Renal Cell Carcinoma With Nivolumab
Cureus
Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma
European Urology
Urology
Nivolumab in the Treatment of Advanced Renal Cell Carcinoma
Oncology in Clinical Practice
Oncology
Nivolumab in Treatment of Renal Cell Carcinoma During Renal Replacement Therapy
Oncology in Clinical Practice
Oncology
